Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus

Background: Chemotherapy regimens for breast cancer treatment can promote vascular dysfunction and lead to high cardiovascular risk. Purpose: To investigate the cardiovascular burden and vascular inflammation in metastatic breast cancer patients receiving CDK 4/6 inhibitors or everolimus in addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Papageorgiou, Christos, Zagouri, Flora, Tampakis, Konstantinos, Georgakopoulou, Rebecca, Manios, Efstathios, Kafouris, Pavlos, Benetos, Georgios, Koutagiar, Iosif, Anagnostopoulos, Constantinos, Dimopoulos, Meletios A., Toutouzas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959765/
https://www.ncbi.nlm.nih.gov/pubmed/33732735
http://dx.doi.org/10.3389/fcvm.2021.638895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959765/
https://www.ncbi.nlm.nih.gov/pubmed/33732735
http://dx.doi.org/10.3389/fcvm.2021.638895

Ejemplares similares